NCT03172455: Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT) |
|
|
| No Longer Available | N/A | | NA | Glassia, Alpha 1 antitrypsin | Impatients N.V. trading as myTomorrows, Kamada, Ltd. | Acute-graft-versus-host Disease, Steroid Refractory Acute Graft Versus Host Disease, Graft-versus-host-disease, Graft Vs Host Disease, Alpha 1-Antitrypsin Deficiency, Alpha-1 Proteinase Inhibitor, Alpha-1 Protease Inhibitor Deficiency, Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant | | | | |
